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The incidence of deep infection has declined since the early 
years of joint replacement surgery (Figure 1). Currently, the 
infection rates are low: around 1% in primary knee replace-
ments and 0.3–0.6% in hip replacements (Phillips et al. 2006, 
Pulido et al. 2008, Jämsen et al. 2010). However, even pro-
spective surveillance programs may underestimate the infec-
tion rates; thus, the true incidence is probably higher (Huotari 
et al. 2010).
Deep infection accounts for up to one quarter of early revi-
sions (Dobzyniak et al. 2006, Mulhall et al. 2006). Recent 
data from the Scandinavian arthroplasty registries show that 
the proportion of revision operations that are due to infec-
tion is increasing (Figure 2). Operating patients with a higher 
inherent infection risk, such as obese patients and those with 
diabetes, and emergence of resistant bacterial strains represent 
additional challenges, and give reason for continuous dedica-
tion to prevent deep infection.
Patient-related infection risk can be reduced e.g. by man-
aging preoperative anemia, glucose control, and elimination 
of harmful lifestyle factors such as smoking. Morbidly obese 
patients represent a special risk group. The principles of infec-
tion prevention in perioperative management are well-docu-
mented, but adherence to the protocols should be improved. 
Care should be taken regarding timely and appropriate admin-
istration  of  antibiotic  prophylaxis.  Combining  intravenous 
antibiotics and antibiotic-impregnated cement further reduces 
deep infection rates. Finally, monitoring of infection rates on 
a local, national, and even an international scale is an essential 
Figure  1.  The  cumulative  revision  rates  (CRRs;  the  proportion  of 
operated  patients  who  underwent  revision  with  time)  with  revision 
for infection as endpoint in consecutive cohorts of primary total knee 
arthroplasties (TKAs) performed in patients with osteoarthritis (OA) in 
1976–2007 in Sweden. The colored areas represent the 95% confi-
dence intervals for the cumulative revision rates for different time peri-
ods. Source: the Swedish Knee Arthroplasty Register, 2009.
Figure 2. The proportions of infections, aseptic loosening, instability, 
and pain for all reasons for revision knee replacements in 1997–2008 
in Denmark. Source: the Danish Knee Arthroplasty Register, Annual 
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part of quality control and is necessary in order to be able to 
identify weaknesses in current infection prevention practices. 
Pathogenesis 
Deep  postoperative  infection  is  traditionally  classified  into 
early infection (< 3 months postoperatively), delayed infec-
tion (3–24 months), and late infection (> 2 years postoper-
atively) (Zimmerli et al. 2004). Approximately one third of 
deep infections occur within 3 months and two-thirds within 
2 years after the index operation (Phillips et al. 2006, Jämsen 
et al. 2009b, Stefánsdóttir et al. 2009a). Hematogenous infec-
tion may occur at any time after the operation, but its propor-
tion increases with time after surgery. Overall, hematogenous 
infections account for up to almost one third of infected joint 
replacements (Pulido et al. 2008, Stefánsdóttir et al. 2009a).
Most of the relevant literature deals with early and delayed 
postoperative  infections  where  the  infecting  pathogen  is 
thought  to  contaminate  the  joint  during  surgery  (Zimmerli 
et al. 2004). These infections are potentially preventable by 
minimizing the possibility of perioperative and early postop-
erative contamination of the prosthesis. 
Patient-related risk of deep infection
In general, any co-morbid condition that impairs host defense 
mechanisms,  prolongs  wound  healing,  or  predisposes  to 
wound-related complications should be considered a poten-
tial risk factor for deep infection. In knee replacements, there 
is good evidence of higher risk of deep infection in patients 
with rheumatoid arthritis (RA), American Society of Anesthe-
siologists (ASA) risk score > 2, diabetes, or morbid obesity 
(Jämsen 2009). Most risk factors are shared for knee and hip 
replacements (Pulido et al. 2008).
Patients  with  RA  have  a  higher  risk  of  deep  infection 
(  Schrama  et  al.  2010).  Biological  anti-rheumatic  drugs  in 
particular  may  predispose  to  wound  infections  (Konttinen 
et  al.  2005).  Other  inflammatory  arthritides  do  not  appear 
to be associated with increased infection risk after primary 
knee  replacement  (Jämsen  et  al.  2009a).  Secondary  knee 
osteoarthritis, earlier fractures, and acute hip fractures espe-
cially are also associated with increased risk of deep infection 
after joint replacement (Ridgeway et al. 2005, Jämsen 2009). 
In knee replacements, poorer preoperative Knee 55 Society 
Scores asssociate with higher risk of deep infection (Jämsen 
et al. 2010). The infection rates are higher in revisions than in 
primary hip and knee replacements. 
ASA risk index is used as a proxy for co-morbidity. The 
risk  of  deep  infection  and  other  postoperative  complica-
tions increases almost exponentially with ASA score. How-
ever, cardiovascular, respiratory, and neurological disorders 
do not appear to result in higher infection rate, even though 
they  increase  the ASA  risk  score  (Peersman  et  al.  2001). 
Accordingly, in the study by Lai et al. (2007), only diabetes 
and urogenital disorders were associated with infected joint 
replacements. Preoperative anemia is predictive of a need for 
allogenic blood transfusions, which in turn have been associ-
ated with higher risk of postoperative infections (Pulido et al. 
2008).
The role of obesity and diabetes should be acknowledged 
when preventing deep infections. Obesity is more common in 
knee replacement recipients than in hip replacement recipients 
(Fehring et al. 2007). The highest infection rates have been 
observed in morbidly obese patients (body mass index ≥ 40 
kg/m2) (Pulido et al. 2008, Dowsey and Choong 2009, Jämsen 
2009). Wound healing problems, including wound infection, 
are common in this patient group but these patients also often 
have underlying conditions such as diabetes or peripheral vas-
cular disease that may give few symptoms but nevertheless 
increase the risk of infection.
Meding et al. (2007) identified diabetes preoperatively in 
15% of joint replacement recipients, only 58% of whom were 
previously diagnosed. Since diabetes increases the risk of sur-
gical site infections (Mangram et al. 1999), screening for dia-
betes might be a reasonable approach (Jämsen 2009). There 
is preliminary evidence to suggest that patients with poorly 
controlled diabetes have a higher risk of postoperative com-
plications (Marchant et al. 2009), including infection (Jämsen 
2009).
Malnutrition and smoking delay wound healing and increase 
the risk of infection (Mangram et al. 1999), as does alcohol 
abuse (Peersman et al. 2001). In contrast to RA, for example, 
these lifestyle-related risk factors, together with obesity and 
glycemic control, are potentially modifiable risk factors.
Smoking should be discontinued 6–8 weeks before surgery. 
In a randomized study, participation in a preoperative smoking 
cessation program was found to reduce postoperative compli-
cation rates, and no wound-related complications occurred in 
the patients who stopped smoking before surgery (Møller et al. 
2002). In an experimental study, use of transdermal nicotine 
patches did not impair wound healing (Sørensen et al. 2003).
 
Optimizing the patient’s condition preoperatively
All current infections should be managed before the opera-
tion. The most common sources of hematogenous infection 
are the skin, and the urinary and respiratory tracts. With hip 
or knee replacement, the skin of the lower extremities should 
be intact. Treatment of asymptomatic bacteriuria, which is 
common in elderly patients, preoperatively is not necessary, 
whereas symptomatic urinary tract infection should probably 
be treated (David and Vrahas 2000). Major dental procedures 
are a potential source of hematogenous infection—although 
the underlying evidence is weak (Uçkay et al. 2008)—and it is 
advisable to perform such operations before joint replacement 
when possible.
Nasal carriage of Staphylococcus aureus, including methi-
cillin-resistant strains, increases the risk of surgical site infec-
tions (Mangram et al. 1999, Yano et al. 2009). Although pre-
operative treatment using nasal mupirocin ointment reduces 
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shown to reduce the risk of surgical site infections in patients 
with nasal S. aureus carriage (van Rijen et al. 2008). 
Perioperative management
The sterile techniques and measures thoroughly described by 
the Centers for Disease Control and Prevention (Mangram et 
al. 1999) should be also used as a routine in joint replacement 
surgery, but the effectiveness of all of these techniques has not 
been evaluated in this field of surgery. 
The duration of preoperative hospitalization should be mini-
mized to reduce the risk of colonization of the patient’s skin 
with  possibly  resistant  hospital-acquired  bacterial  strains. 
Arrival on the day of operation is becoming a routine. 
Antiseptic agents do not appear to differ much regarding 
postoperative infection rates (Edwards et al. 2009), but the 
long-acting chlorhexidine is favored (Fletcher et al. 2007). 
Preoperative bathing, showering using antiseptic agents, or 
use of plastic adhesive drapes has not been found to reduce 
the  risk  of  postoperative  infections  (Webster  and  Osborne 
2007, Webster and Alghamdi 2009). Hair removal, if done at 
all, should be done immediately preoperatively and using clip-
pers or depilatory agents (Mangram et al. 1999, Fletcher et al. 
2007).
The effectiveness of different solutions for hand washing 
probably  depends  not  only  on  their  antiseptic  activity  but 
also on the surgeons’ compliance, scrubbing technique, and 
duration of the scrub (Mangram et al. 1999). Surgical gowns, 
masks and caps, and personal exhaust systems reduce bacte-
rial counts in the air of the operating room but it is unclear 
whether different kinds of surgical attire can affect postopera-
tive infection rates (Mangram et al. 1999, Fletcher et al. 2007). 
Double-gloving and use of indicator gloves probably reduce 
the risk of hand contact between the surgeon and the patient, 
and can be recommended. 
Hypothermia and dehydration may impair microcirculation 
in the operating field and thereby weaken host defense mecha-
nisms (Mangram et al. 1999). Maintenance of normothermia 
during the operation has resulted in lower rates of postopera-
tive infection in general and abdominal surgery (Forbes et 
al. 2009), but there has been a lack of such studies in joint 
replacement surgery. Sufficient oxygenation may also be of 
importance (Mangram et al. 1999).
Surgical stress induces insulin resistance; this leads to a 
catabolic  state  and  hyperglycemia,  which  may  persist  for 
weeks postoperatively and predispose the patient to wound-
related complications (Ljungqvist et al. 2007). Importantly, 
this may also occur in non-diabetic patients. In thoracic sur-
gery, postoperative hyperglycemia increases the risk of medi-
astinitis, and conversely, strict glycemic control postopera-
tively has resulted in lower infection rates (Furnary and Wu 
2006). Although perioperative hyperglycemia occurs in up to 
three quarters of non-diabetic patients undergoing knee or hip 
replacement (Pili-Floury et al. 2009), there have been no stud-
ies evaluating the association between perioperative hyper-
glycemia and postoperative infection rate in the field of joint 
replacement surgery. 
Larger constrained and especially hinged prostheses used in 
the management of severe knee deformities carry a higher risk 
of infections than non-constrained TKR (Jämsen et al. 2009a). 
Unicompartmental knees (UKR) have lower infection rates 
(approximately one third of that following total knee replace-
ment) (Furnes et al. 2007, Swedish Knee Arthroplasty Regis-
ter 2009). Prolonged operating time (> 2.5 h)—reflecting the 
complexity of surgery or the inexperience of the surgeon—has 
been associated with increased infection rate in several stud-
ies (Peersman et al. 2001, Gastmeier et al. 2005, Pulido et al. 
2008, Dale et al. 2009, Jämsen et al. 2010). 
Prompt  surgical  management  of  wound-related  problems 
is advocated by some authors, but there have been no stud-
ies  comparing  early  aggressive  management  vs.  nonopera-
tive management in clinical practice. In a large retrospective 
review, revision and deep infection rates were found to be high 
also after early surgical management of wound-healing prob-
lems, but the study lacked a comparison group with nonopera-
tively treated patients (Galat et al. 2009).
Thromboprophylaxis increases the risk of hematoma and 
consequent wound-related problems. Preoperative administra-
tion of low-molecular-weight heparin was found to be associ-
ated with more infected knee replacements in a case-control 
study (Asensio et al. 2005). Data from prospective trials is 
lacking, since surgical site infections have not been analyzed 
as outcome in the existing randomized trials. 
Closed suction drains are a potential entry point of infec-
tion, but do not seem to affect the wound infection rate (Parker 
et al. 2007). Preliminary results suggest that intra-articular 
catheters  used  for  administering  analgesics  postoperatively 
may also predispose to wound contamination and infection 
(Reeves and Skinner 2009). 
Antibiotic prophylaxis
Systemic intravenous antibiotic prophylaxis reduces the risk 
of postoperative infections (AlBuhairan et al. 2008). Cephalo-
sporins are widely used, based on their good efficacy against 
staphylococcal  species  and  uropathogens  (Mangram  et  al. 
1999). Vancomycin is indicated in high-risk patients carrying 
methicillin-resistant Staphylococcus aureus (Mangram et al. 
1999, Fletcher et al. 2007, Scottish Intercollegiate Guidelines 
Network 2008). If the patient has allergy to beta-lactam anti-
biotics, clindamycin or vancomycin can be used.
The association between time of administration of the anti-
biotic and surgical site infection rate can be presented as a 
U-shaped curve with higher risk of infection both before and 
after the optimal time frame of administration. In a recent large 
study, the lowest infection rates were seen when administra-
tion occurred between 30–60 min before incision (Weber et al. 
2008) whereas in another study focusing on total hip replace-
ments, administration within 30 min before incision resulted 
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of infection is particularly high if administration occurs after 
the incision. In both of these studies, cefuroxime or cefazolin 
was used most frequently. With other antibiotics, the optimal 
time for administration may differ, depending on the pharma-
cokinetics. Nevertheless, in knee replacements the antibiotic 
infusion should be finished at least 10 min before application 
of a tourniquet (Tomita and Motokawa 2007). 
The studies and guidelines concerning duration of routine 
antibiotic  prophylaxis  have  come  to  varying  conclusions 
(Engesæter  et  al.  2003,  van  Kasteren  et  al.  2007,  Scottish 
Intercollegiate Guidelines Network 2008). In a large Norwe-
gian register study, 4 doses of intravenous antibiotics on the 
day of operation were more effective than fewer doses in pri-
mary hip replacements (Engesæter et al. 2003). Others have 
reported no difference (van Kasteren et al. 2007). In prolonged 
surgeries—including  bilateral  operations—additional  doses 
may be required, especially when an antibiotic with a short 
half-life is used (Stefánsdóttir et al. 2009b).
In Scandinavia, antibiotic-impregnated cement is also used 
routinely  in  primary  joint  replacements  (Engesæter  et  al. 
2003, Jämsen et al. 2009a), although this practice has been 
questioned  and  the  scientific  data  from  randomized  stud-
ies are controversial (van de Belt et al. 2001). The basis for 
this  practice  comes  largely  from  registry-based  studies  on 
hip  replacements.  Initially,  a  Norwegian Arthroplasty  Reg-
ister study showed that combining antibiotics intravenously 
and in cement (combined antibiotic prophylaxis) was more 
effective that either technique alone in lowering deep infec-
tion rates (Espehaug et al. 1997). The result was repeated in 
a larger series followed for up to 16 years (Engesæter et al. 
2003) (Figure 3). In a recent large Norwegian register study, 
uncemented hip replacements had an overall 1.4-fold risk of 
revision for infection, compared to hip prostheses fixed with 
antibiotic-impregnated  cement  (Dale  et  al.  2009).  Similar 
results concerning the effect of antibiotic-impregnated cement 
in primary and revision knee replacements were reported in 
a Finnish study (Jämsen et al. 2009a) and by the Australian 
National Joint Registry (Australian Orthopaedic Association 
2009).
Emphasizing the value of combined antibiotic prophylaxis 
in high-risk operations, Chiu et al. have shown in a series of 
randomized  studies  that  combining  antibiotic-impregnated 
cement  and  systemic  antibiotic  prophylaxis  prevents  deep 
infection in knee replacements performed under suboptimal 
operative conditions (Chiu et al. 2002) and with a high base-
line risk of infection (patients with diabetes, revision knee 
replacements) (Chiu et al. 2001, Chiu and Lin 2009).
Antibiotic-impregnated cement has been thought to increase 
the risk of allergic reactions, emergence of resistant bacterial 
strains, and aseptic loosening of the prosthesis, but to date 
there is little evidence to support these concerns. Registry-
based studies can be criticized, as provider- and patient-related 
factors not recorded in the arthroplasty registers may affect 
the results. However, randomized studies on the effectiveness 
of antibiotic-impregnated cement are not feasible for ethical, 
practical, and statistical reasons. 
Provider-related issues
The lowest infection rates have been reported from special-
ized  orthopedic  units  with  high  annual  operation  volumes 
(Peersman et al. 2001, Phillips et al. 2006, Pulido et al. 2008, 
Jämsen et al. 2010). In joint replacement surgery, the asso-
ciations between operation volume and short-term outcomes 
have been based mostly on administrative health register data, 
such as Medicare databases (Shervin et al. 2007).
Most studies concerning the effect of hospital volume have 
found  no  association  between  volume  and  infection  rate 
(Shervin et al. 2007). In a recent study using arthroplasty reg-
ister data, the type of operating hospital (university, central, 
district, or other) and hospital annual operation volume was 
not associated with the rate of infection at medium-term fol-
low-up (Jämsen 2009).
At the surgeon level, a positive association between opera-
tion volume and infection rates seems clearer. The published 
studies, including one using prospectively collected infection 
surveillance  data,  suggest  that  surgeons  should  perform  at 
least 20–50 joint replacement  operations per year (Muilwijk 
et al. 2007, Shervin et al. 2007). In larger units, it is advis-
able that joint replacement surgery should be centralized to a 
smaller group of surgeons.
Clean-air  measures  and  vertical  laminar  flow  have  been 
thought to lead to lower infection rates (Lidwell et al. 1987, 
Mangram et al. 1999). These early results have been questioned 
in more recent series where intravenous antibiotic prophylaxis 
has been used routinely (Brandt et al. 2009). However, in a 
post hoc analysis Lidwell et al. (1987) showed that combining 
 
Figure 3. Prosthesis survival with revision due to infection as endpoint 
following 45,250 primary total hip replacements, performed in Norway 
in  1987–2007,  where  no  antibiotic  prophylaxis  (None),  intravenous 
antibiotic prophylaxis (S), antibiotic-impregnated cement (C), or both 
intravenous antibiotic prophylaxis and antibiotic-impregnated cement 
(SC) was used. 2,137 operations were performed in a clean-air enclo-
sure, 21,627 in operating theaters with laminar flow, and the remaining 
operations in operating theaters with standard air ventilation.664  Acta Orthopaedica 2010; 81 (6): 660–666
all available techniques (laminar air flow, body exhaust suits 
or surgical enclosures, and antibiotic prophylaxis) resulted in 
the lowest infection rate—of only 0.1%. Antibiotics appear to 
be most cost-effective, and supplementary use of other pro-
phylactic  techniques  (antibiotic-impregnated  cement,  body 
exhaust suits, and sterile surgical enclosures) increases the 
cost of prophylaxis—but on the other hand reduces the infec-
tion rate (Persson et al. 1999).
The degree of adherence to infection control guidelines is 
often low in clinical practice. Timely inappropriate adminis-
tration of antibiotic prophylaxis occurs in 13–50% of cases 
(Bedouch et al. 2004, Stefánsdóttir et al. 2009b). Selection, 
dosing, and duration of antibiotic prophylaxis has also been 
reported  to  vary  (Bedouch  et  al.  2004,  Stefánsdóttir  et  al. 
2009b).
Monitoring of infection rates is important for identification 
of inappropriate practices, and systematic prospective surveil-
lance has been shown to reduce infection rates (Mangram et al. 
1999, Gastmeier et al. 2005). Personnel-related factors (which 
partly explain the deficiencies) can be minimized using check-
lists and reminders and decision support, which have both been 
shown to result in lower rates of surgical site infection (Webb 
et al. 2006, Haynes et al. 2009). Evidence showing that strict 
adherence results in fewer infections is lacking. Nevertheless, 
it has been estimated that 20% of hospital-acquired infections 
can be prevented by improving adherence to infection control 
measures (Harbarth et al. 2003). 
Arthroplasty registers in the study of infected joint 
replacement
Large series of patients are required to study the factors asso-
ciated with infected joint replacement, because the infection 
rates are low. Such materials cannot be collected easily in indi-
vidual hospitals. Thus, arthroplasty registries are necessary in 
this field of research. However, these registries underestimate 
the true incidence of deep infections, as they record reliably 
only revision joint replacements (Jämsen et al. 2009b). As 
early surgery with prosthesis retention is becoming more pop-
ular for acute infections, incomplete registration is of increas-
ing relevance. 
In  addition,  the  registries  do  not  have  a  uniform  defini-
tion of infection and the validity of diagnosis of infections in 
arthroplasty registry data relies on the reports made by oper-
ating surgeons and reporting activity. Without microbiologi-
cal confirmation, the diagnosis remains uncertain. Finally, the 
data concerning patient-related risk factors is in most cases 
insufficient (i.e. data on co-morbid diseases). Although more 
patient-related data could be recorded by registries, this might 
make registration and reporting of data more difficult and have 
a negative effect on the quality and coverage of data. 
Using  data  from  other  electronic  sources  is  one  way  to 
improve  validity.  Reoperations  other  than  revision  joint 
replacements (e.g. debridements and partial revisions) can be 
detected using hospital discharge data from patient registries. 
Patient registry data can also be used to analyze the effects 
of co-morbid diseases in more detail. Regional and national 
infection surveillance programs have been established in some 
countries, and act as a potential source of microbiological 
data—although their follow-up period is usually restricted to 
1 year (Mangram et al. 1999, Huotari et al. 2010).
Thus, registry-based analyses cannot fully replace clinical 
studies, but they are still an invaluable source for hypotheses 
generation, for identification of case patients to be evaluated 
in more detail (see e.g. Stefánsdóttir et al. 2009a, b), and for 
quality control.
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